Table: OncoTherapy Science - 9-MTH group results

OncoTherapy Science

06/02/2026 08:00

Feb 6 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            597 mln             563 mln                    
                 (+6.1 pct)          (+20.9 pct)                  
  Operating     loss 694 mln        loss 698 mln                  
  Recurring     loss 720 mln        loss 716 mln                  
  Net           loss 783 mln        loss 717 mln                  
  EPS           loss 2.52 yen       loss 2.78 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T